Your Location:Home >Products >Fine Chemicals >13488-22-7

13488-22-7

  • Product Name:5,8,11-EICOSATRIYNOIC ACID
  • Molecular Formula:C20H28O2
  • Molecular Weight:300.44
Inquiry

Product Details

pd_meltingpoint:70.5-71.5 °C

Purity:99%

Buy 5,8,11-EICOSATRIYNOIC ACID 13488-22-7 Inosine Best Price Supply Ability

  • Molecular Formula:C20H28O2
  • Molecular Weight:300.44
  • Vapor Pressure:2.78E-10mmHg at 25°C 
  • Melting Point:70.5-71.5 °C 
  • Refractive Index:1.507 
  • Boiling Point:473.8 °C at 760 mmHg 
  • PKA:4.61±0.10(Predicted) 
  • Flash Point:221.9 °C 
  • PSA:37.30000 
  • Density:0.99 g/cm3 
  • LogP:4.78230 

5,8,11-EICOSATRIYNOIC ACID(Cas 13488-22-7) Usage

Uses

ETI is a leukotriene antagonist and selective 5-LO (5-lipoxygenase) inhibitor.

Definition

ChEBI: A C20 polyunsaturated fatty acid having three triple bonds in the 5-, 8- and 11-positions.

Biological Activity

5,8,11-eicosatriynoic acid is a selective inhibitor of lipoxygenases with id50 values of 24 μm and 340 μm for n-8 lipoxygenase and fatty acid cycle-oxygenase , respectively[1][2].fatty acid cycle-oxygenase and n-8 lipoxygenase catalyze the initial reactions which lead to the formation of three major arachidonic acid metabolites in human platelets. in several tissues, these two enzymes act concomitantly on arachidonic acid [1].5,8,11-eicosatriynoic acid (5,8,11-et) is a selective inhibitor of lipoxygenases with id50 values of 24 μm and 340 μm for n-8 lipoxygenase and fatty acid cycle-oxygenase, respectively. 5,8,11-eicosatriynoic acid was useful for studies on physiological and pathophysiological roles of 12 l-hydroxy-5,8,10,14-eicosatetraenoic acid formation in various tissues [1]. in mouse mastocytoma cells, 5,8,11-eicosatriynoic acid inhibited a23187 and l-cysteine induced leukotriene c (ltc4) biosynthesis with id50 value of 5 μm [2].

references

[1]. hammarstrm s. selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. biochim biophys acta. 1977 jun 22;487(3):517-9. [2]. orning l, hammarstrm s. inhibition of leukotriene c and leukotriene d biosynthesis. j biol chem. 1980 sep 10;255(17):8023-6.

InChI:InChI=1/C20H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-8,11,14,17-19H2,1H3,(H,21,22)

13488-22-7 Relevant articles

Selective inhibition of platelet n — 8 lipoxygenase by 5,8,11-eicosatriynoic acid

Sven Hammarström

, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Volume 487, Issue 3, 22 June 1977, Pages 517-519

5,8,11-Eicosatriynoic acid selectively inhibited n — 8 lipoxygenase (ID50 = 24 μM) in comparison to fatty acid cyclo-oxygenase (ID50 = 340 μM) in human platelets. 5,8,11,14-Eicosatetraynoic acid inhibited the enzymes less selectively (ID50 values: 4 μM for the lipoxygenase and 8 μM for the cyclooxygenase)....

Eicosatriynoic acid esters and amides and their application in pharmaceutical and cosmetic practice

-

, (2008/06/13)

Compound, corresponding to the formula i...

13488-22-7 Process route

1-bromoundec-2-yne
18495-28-8

1-bromoundec-2-yne

5,8,11-eicosatriynoic acid
13488-22-7

5,8,11-eicosatriynoic acid

Conditions
Conditions Yield
Multi-step reaction with 3 steps
1: (i) EtMgBr, (ii) CuCl, THF, (iii) /BRN= 1816644/
2: PBr3, Py / diethyl ether
3: (i) EtMgBr, THF, (ii) CuCN, (iii) /BRN= 1817884/
With pyridine; phosphorus tribromide; In diethyl ether;
 
tetradeca-2,5-diyn-1-ol
13488-14-7

tetradeca-2,5-diyn-1-ol

5,8,11-eicosatriynoic acid
13488-22-7

5,8,11-eicosatriynoic acid

Conditions
Conditions Yield
Multi-step reaction with 2 steps
1: PBr3, Py / diethyl ether
2: (i) EtMgBr, THF, (ii) CuCN, (iii) /BRN= 1817884/
With pyridine; phosphorus tribromide; In diethyl ether;
 

13488-22-7 Upstream products

  • 53293-00-8
    53293-00-8

    hex-5-ynoic acid

  • 13488-18-1
    13488-18-1

    1-bromo-tetradeca-2,5-diyne

  • 18495-28-8
    18495-28-8

    1-bromoundec-2-yne

  • 13488-14-7
    13488-14-7

    tetradeca-2,5-diyn-1-ol

13488-22-7 Downstream products

  • 14602-39-2
    14602-39-2

    methyl 5Z,8Z,11Z eicosatrienoate

Relevant Products